Q8IBB8 AF NFT

Uncharacterized protein MAL8P1.12

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiglj24djarjjiekepfihq5yieqgaffu2y22jbyufkaicfbib5k6fu/metadata.json
IPFS of structure file: 
bafybeibwx7c4s3zu6dmywwwvage5eqe645sp34yyg4uyo3vzurpmmz6odq/AF-Q8IBB8-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xca6be69Db99769597c709655C19B8591C36aFB61
First NFT owner address (bech32): 
genesis1ef47d8deja54jlrsje2urxu9j8pk47mpl3lpsk
Current NFT ID #536485 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
536485
Accession (UniProt):
Q8IBB8
Name::
Uncharacterized protein MAL8P1.12
Experimental Method:
Predicted structure
Sequence source:
PLASMODIUM FALCIPARUM (ISOLATE 3D7)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q8IBB8 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q8IBB8|YPF15_PLAF7 Uncharacterized protein MAL8P1.12 OS=Plasmodium falciparum (isolate 3D7) OX=36329 GN=MAL8P1.12 PE=1 SV=1 MSEESFDDTNKAFENEKDIILEKIVKDENNLNNCSNMINMDDVENMKKELYVLHKKDEEIENNVDCFSGDKYNVENVINLKKKKKKDEDTDSSYYKTTLDEVYDTSDISTDEMLSNYSSSEDNNNIEMNIINDFYLKDDNTYCLEWNSDIINVLSEEIKEKEKLLEDENKDICNMKSRFLKLEKYVNIKKKKIINIKKNIEEKRKIEFDEKEIFKCLQIKNDFLKKENKKIELEREKNNKKIIETQNNITTCQKNIDDIKKELILKENELNDFINKIKIIQQEEYEIEKIKLSKDKEIQNVSYNLEKYNNEKIQQDKKYEQVKMNNMKFDIELKSIIQEYYDIKKDIKNISNKYICIMDMIKCRDKTIYKFEKDYTKTIHKEKQLQNKCLHKQNLINTQKDKNIILNNQIKKIQFDINKIRKELNDKQMSYDKTIIDRDHLNKEYEYEIVEIKEKLQEEKKSLENTLQHLNETYITMSTNYEESKNEYEKEQVNNIEKNDLIKSSEQILVQLQNKLQKLLDEIKSLDLEKFQLTQTLQVIKNDYITLEADVLGTQIKIKQIKSNIKKTEKELERQKEMLYKFDFQTQVLTKKINMISGISTFEKKKENQKKIILLEKELYKNEDIYNTLNNEMKRINIEIKNIKLYQNELQEQKMNYKNLYEKLQLEIKSLESTINNEIKEKENIMLIELNLKIELDKLKSTFSKHVDNLNICKKEKKENMNNAKLSEQDINAHMESLKVIIKNINDEIHKLNIQLYEKKNKSNNLQLKLNSIIICNQKNKDQKDICPNENQHIYYKMKIDQDIINLKEQLKKINEQIDKENIETKNFQRTLDDIIQTNKEFNDNIKSIDPQYKILLKKKNKLNKKWEQINDHINNLETNINDYNKKIKEGDSQLNNIQLQCENIEQKINKIKESNLKVENNINDLFIKIERASNQLKKNLAPTTNMMKLKNKQIKDDENNLSNNNNNNNNNNNNINVNVNVNCEPVPLEKHIFKQIQMESLKEKLSLLMECFKNNIDNVIMKEVFNLIETAE